A Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in HER2+ Early Breast Cancer Patients
Clinical trial NCT03013504 · COMPLETED
Trial details
- NCT number
- NCT03013504
- Sponsor
- Prestige Biopharma Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-19
- Primary completion
- 2019-04-19
- Enrollment
- 503
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.